ARCHIVES

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million

January 7, 1983

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002

Clinical Trials Approved By NCI Listed For September

September 24, 2004

In Brief: Ultmann New AACI President, Robert Day Named President Elect; Hulka New DCPC Board Chairman

July 20, 1984

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983